Before citing numbers and statistics that will tell you something you may or may not already know. Briefly explain how to calculate survival rates. Survival rate is 5 years of study referred to patients who survive 5 years or more after initial diagnosis. This is useful for determining prognosis, or the perspective of patients. As the diagnosis and treatment started 5 years prior to any diagnosis presented today, new cases are expected to have a better prognosis, due to changes in treatment.
It develops in the male gland that may spread to other parts of the body, especially the lymph nodes and bones. It can cause difficulty urinating, pain or erectile dysfunction, along with any number of other symptoms that may occur later in the disease. The Traditional treatments are surgery, radiation, and protons.
1) Second only to lung cancer-related death cancer.
2) Until recently in the number of deaths from the rose. In 1932 17 per 100,000 men died from this, in 1991 the figure rose to 25 in 100,000. The reasons for these increases are speculative at best.
3) The second most common cancer in men, the first skin cancer welfare.
4) 1 in 35 die of this cancer. He claims 10% of all cancer-related deaths for men.
5) According to the American Society Cancer, almost 100% of patients survive 5 years (99.9% white and 97.6% of black men,) that the rate is 91% at 10 years and 76% at age 15. Please note the above mentioned factor when considering the survival rates.
6) The average age of deaths related to '98 to '02 was 80, and almost no deaths in the age of 44 years.
7) Stage at diagnosis is important. The survival rate is nearly 100% for the local diagnosis or regional level with the rate dropping to 33.3% of cancers or distant metasized.
There is a lifetime risk of more than 17% per day of man is born today be diagnosed with prostate cancer.
9) that there are rarely symptoms in the early stages. The diagnosis usually starts because of an elevated PSA (Prostate-Specific ) Antigen count in a routine blood test.
10) The main reasons for developing this cancer are still unclear. Although many believe that age, genetics and diet to be contributing factors.
The facts presented here are the same facts presented by the American Cancer Society, and Integration Education, and both references seem to point to the same conclusions. Early detection of this potentially fatal condition is imperative to increase the chances of survival. Meanwhile, ongoing research makes progress very day.
Jamie Vanderhorst has been covering Prostate Cancer for the last 10 years, working as a professional writer. One of Jamie’s areas of knowledge is on Prostate Cancer survival rates.
Bronchoscopy – lung cancer that invaded the tracheal carina
|
|
Characteristics and outcomes of patients with unresected early-stage non-small cell lung cancer.: An article from: Southern Medical Journal $5.95 This digital document is an article from Southern Medical Journal, published by Southern Medical Association on October 1, 2002. The length of the article is 2130 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation … |
|
|
Lung Cancer $18.14 Lung cancer is the top cancer killer in the U.S. Yet it receives little attention from the media, and those with lung cancer suffer more blame and stigma than other cancer patients, even though 50 percent of them are former smokers or have never smoked. Lung cancer treatments and the daunting prognosis for some types and stages of lung cancer can significantly impact quality of life.In straightforward language, Lung Cancer: Making Sense of Diagnosis, Treatment & Options addresses its readers’ medical, emotional, and support needs. The book includes stories from patients themselves, their families and their healthcare professionals.Author and patient advocate Lorraine Johnston emphasizes using knowledge to dispel fear. The content has been reviewed by top medical experts and physicians in the field. Readers will encounter medical facts simply explained, advice to ease their daily life, and tools to be strong advocates for themselves or a family member. |
|
|
Lung Cancer $133.14 Leading physician scientists and noted researchers describe step-by-step techniques for lung cancer diagnosis based on the molecular analysis of clinical samples. These experts review currently accepted treatments and outline a variety of novel therapies, including those based on gene therapy, immunotherapy, and chemoprevention, and show how these newly improved techniques can give a better appreciation of the prognosis associated with the particular mutation uncovered by the technique. These methods use a variety of molecular techniques, including the manipulation of gene expression and the alteration of immune status, to combat lung cancer. |
|
|
Cancer Imaging: Lung and Breast Carcinomas $192.61 This two-volume reference book will present imaging technology currently used in clinics or at experimental stages for diagnosis and/or early detection of various cancers, including anticancer vaccines, surgical techniques, chemotherapy, radiation, and gene therapies. Cancers discussed will include breast, lung, liver, prostate, cervical, brain, gastrointestinal, ovarian, gallbladder, esophageal, head and neck, bronchial, bone, thyroid, pancreatic, lymphoma, melanoma, and multiple myeloma malignancies. Approximately 100 research scientists and clinicians from more than 20 countries will contribute chapters. – Concentrates on the application of imaging technology to the diagnosis and prognosis of lung and breast carcinomas, the two major world-wide malignancies- Addresses relationship between radiation dose and image quality- Discusses the role of molecular imaging in identifying changes for the emergence and progression of cancer at the cellular and/or molecular levels |
|
|
Methods of Cancer Diagnosis, Therapy and Prognosis: General Methods and Overviews, Lung Carcinoma and Prostate Carcinoma $260 Methods of Cancer Diagnosis, Therapy and Prognosis: General Methods and Overviews, Lung Carcinoma and Prostate Carcinoma |
|
|
Lung Cancer $28.01 Lung Cancer |
